|
|
|
Attachment Cb. State and County Representative Data Collection Instrument |
|
|
|
|
|
|
|
|
|
|
|
XDR TB Contact Investigation: A Cost Assessment |
|
Form Approved |
|
|
|
|
|
|
|
|
|
Costs to state health departments |
|
OMB No. 0920-0879 |
|
|
|
|
|
|
|
|
|
|
|
Expiration Date 03/31/2018 |
|
|
|
|
|
|
|
|
|
Preparation for the contact investigation and initial assessments of each contact |
|
|
|
|
|
|
|
|
|
|
|
Today's date |
1/26/2021 |
|
|
|
|
|
|
|
|
|
|
Date that data provided to the CDC represents as endpoint of data collection |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
Location and collaborator information |
Name |
Job title |
|
|
|
|
|
|
0 |
1 |
|
State |
|
|
|
|
|
|
|
|
0 |
2 |
|
Who reported the data collected in this sheet? |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
Contact investigation outcomes |
Number |
Notes |
|
|
|
|
|
|
2 |
3 |
|
Total number of hours identifying contacts in your state |
|
|
|
|
|
|
|
|
2 |
4 |
|
Total number of contacts identified in your state |
|
|
|
|
|
|
|
|
2 |
5 |
|
Number of high priority contacts or 'close contacts' |
|
|
|
|
|
|
|
|
2 |
6 |
|
Number of medium priority contacts |
|
|
|
|
|
|
|
|
2 |
7 |
|
Number of low priority contacts or 'casual contacts' |
|
|
|
|
|
|
|
|
2 |
8 |
|
Total number of contacts evaluated for TB in your state |
|
|
|
|
|
|
|
|
1 |
9 |
|
How confident are you that this represents the total number of actual contacts? |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
Tests and results for TB infection and disease |
Administered |
# positive |
# negative |
# indeterminate |
Notes |
|
|
|
|
|
|
Tuberculin skin testing |
|
|
|
|
|
|
|
|
2 |
10 |
|
Number of tuberculin skin test (TST) placements with TB education |
|
|
|
|
|
|
|
|
5 |
11 |
|
Number of TST test readings |
|
|
|
|
|
|
|
|
|
|
|
IGRA testing |
|
|
|
|
|
|
|
|
5 |
12 |
|
Number of QuantiFERON Gold In-tube (QFT-GIT) IGRA tests |
|
|
|
|
|
|
|
|
5 |
13 |
|
Number of T-spot IGRA tests |
|
|
|
|
|
|
|
|
|
|
|
Testing for TB disease |
|
|
|
|
|
|
|
|
5 |
14 |
|
Number of physical examinations |
|
|
|
|
|
|
|
|
5 |
15 |
|
Number of chest x-rays (CXR) |
|
|
|
|
|
|
|
|
2 |
16 |
|
Number of sputum inductions |
|
|
|
|
|
|
|
|
5 |
17 |
|
Number of smear microscopy and culture tests |
|
|
|
|
|
|
|
|
5 |
18 |
|
Number of nucleic acid amplification (NAA) tests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
Risk factors for developing TB disease after infection |
Number |
Notes |
|
|
|
|
|
|
|
|
|
Number of contacts who were born in any of the following regions |
|
|
|
|
|
|
|
|
2 |
19 |
|
Africa |
|
|
|
|
|
|
|
|
2 |
20 |
|
Asia |
|
|
|
|
|
|
|
|
2 |
21 |
|
Pacific Islands |
|
|
|
|
|
|
|
|
2 |
22 |
|
Central America |
|
|
|
|
|
|
|
|
2 |
23 |
|
South America |
|
|
|
|
|
|
|
|
2 |
24 |
|
Mexico |
|
|
|
|
|
|
|
|
2 |
25 |
|
Eastern Europe |
|
|
|
|
|
|
|
|
2 |
26 |
|
Caribbean |
|
|
|
|
|
|
|
|
2 |
27 |
|
Middle East |
|
|
|
|
|
|
|
|
2 |
28 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
Number of contacts who have lived or travelled in any of the following regions for more than one month |
|
|
|
|
|
|
|
|
2 |
29 |
|
Africa |
|
|
|
|
|
|
|
|
2 |
30 |
|
Asia |
|
|
|
|
|
|
|
|
2 |
31 |
|
Pacific Islands |
|
|
|
|
|
|
|
|
2 |
32 |
|
Central America |
|
|
|
|
|
|
|
|
2 |
33 |
|
South America |
|
|
|
|
|
|
|
|
2 |
34 |
|
Mexico |
|
|
|
|
|
|
|
|
2 |
35 |
|
Eastern Europe |
|
|
|
|
|
|
|
|
2 |
36 |
|
Caribbean |
|
|
|
|
|
|
|
|
2 |
37 |
|
Middle East |
|
|
|
|
|
|
|
|
2 |
38 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
Medical risk factors |
|
|
|
|
|
|
|
|
2 |
39 |
|
Number of contacts with a history of LTBI |
|
|
|
|
|
|
|
|
2 |
40 |
|
Number of contacts with a history of TB disease |
|
|
|
|
|
|
|
|
2 |
41 |
|
Number of contacts that had received the BCG vaccine |
|
|
|
|
|
|
|
|
2 |
42 |
|
Number of contacts with diabetes |
|
|
|
|
|
|
|
|
2 |
43 |
|
Number of contacts with HIV/AIDS |
|
|
|
|
|
|
|
|
2 |
44 |
|
Number of contacts with autoimmune disease or other immunosuppressive condition |
|
|
|
|
|
|
|
|
2 |
45 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
Non medical risk factors |
|
|
|
|
|
|
|
|
2 |
46 |
|
Number of contacts that were close contacts of someone with TB disease other than the index case |
|
|
|
|
|
|
|
|
2 |
47 |
|
Number of contacts under 5 years old |
|
|
|
|
|
|
|
|
2 |
48 |
|
Number of contacts that have been a resident of a correctional facility in the past year |
|
|
|
|
|
|
|
|
2 |
49 |
|
Number of contacts that have ever used injection drugs |
|
|
|
|
|
|
|
|
2 |
50 |
|
Number of contacts that were homeless in the past year |
|
|
|
|
|
|
|
|
2 |
51 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
Cost of testing for TB infection and disease |
Cost per service |
Who paid for it |
Notes |
For checking |
|
|
|
|
3 |
52 |
|
Tuberculin Skin Tests (TST) |
|
|
|
|
|
|
|
|
3 |
53 |
|
Quantiferon Gold In Tube (QFT-GIT) IGRAs |
|
|
|
no |
|
|
|
|
3 |
54 |
|
T-spot IGRAs |
|
|
|
no |
|
|
|
|
3 |
55 |
|
Physical examinations |
|
|
|
no |
|
|
|
|
3 |
56 |
|
Chest X-rays (CXR) |
|
|
|
no |
|
|
|
|
3 |
57 |
|
Sputum inductions |
|
|
|
no |
|
|
|
|
3 |
58 |
|
Sputum smear and cultures |
|
|
|
no |
|
|
|
|
3 |
59 |
|
Nucleic acid amplification (NAA) tests |
|
|
|
no |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
Cost of testing for other illnesses that are risk factors for TB disease |
Number of services provided |
Cost per service |
Who paid for it |
Notes |
|
|
|
|
|
|
|
HIV testing |
|
|
|
|
|
|
|
|
4 |
60 |
|
ELISA |
|
|
|
|
|
|
|
|
4 |
61 |
|
Western blot |
|
|
|
|
|
|
|
|
4 |
62 |
|
Rapid diagnostic test |
|
|
|
|
|
|
|
|
|
|
|
Diabetes testing |
|
|
|
|
|
|
|
|
4 |
63 |
|
Hemoglobin A1C test |
|
|
|
|
|
|
|
|
4 |
64 |
|
Blood glucose test |
|
|
|
|
|
|
|
|
|
|
|
Kidney disease testing |
|
|
|
|
|
|
|
|
4 |
65 |
|
Urinalysis |
|
|
|
|
|
|
|
|
4 |
66 |
|
Ultrasound |
|
|
|
|
|
|
|
|
4 |
67 |
|
Computerized tomography |
|
|
|
|
|
|
|
|
4 |
68 |
|
Biopsy |
|
|
|
|
|
|
|
|
|
|
|
Any other test |
|
|
|
|
|
|
|
|
4 |
69 |
|
please indicate |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
Cost of LTBI treatment |
Number of regimens initiated |
Cost per dose |
Doses taken |
Who paid for it |
Notes |
|
|
|
5 |
70 |
|
6H Isoniazid (INH) |
|
|
|
|
|
|
|
|
5 |
71 |
|
9H Isoniazid (INH) |
|
|
|
|
|
|
|
|
5 |
72 |
|
4R Rifampin (RIF) |
|
|
|
|
|
|
|
|
5 |
73 |
|
3HT Isoniazid (INH) Rifapentine (RPT) |
|
|
|
|
|
|
|
|
5 |
74 |
|
Cycloserine (CYC) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
Personnel costs |
Number of personnel |
Total hours spent on XDR contact investigation |
Gross Annual Salary without benefits
|
Percent fringe benefit |
Who paid for it |
Notes |
|
|
|
|
|
Investigative personnel |
|
|
|
|
|
|
|
|
7 |
75 |
|
Outreach workers |
|
|
|
|
|
|
|
|
7 |
76 |
|
Nurse consultants |
|
|
|
|
|
|
|
|
7 |
77 |
|
Statisticians |
|
|
|
|
|
|
|
|
7 |
78 |
|
Epidemiologists |
|
|
|
|
|
|
|
|
7 |
79 |
|
Translators |
|
|
|
|
|
|
|
|
|
|
|
Health care providers |
|
|
|
|
|
|
|
|
7 |
80 |
|
Nursing supervisors |
|
|
|
|
|
|
|
|
7 |
81 |
|
Nurses |
|
|
|
|
|
|
|
|
7 |
82 |
|
Physicians |
|
|
|
|
|
|
|
|
7 |
83 |
|
Counsellors |
|
|
|
|
|
|
|
|
7 |
84 |
|
Social workers |
|
|
|
|
|
|
|
|
7 |
85 |
|
Volunteers |
|
|
|
|
|
|
|
|
|
|
|
Administrative personnel |
|
|
|
|
|
|
|
|
7 |
86 |
|
Program managers |
|
|
|
|
|
|
|
|
7 |
87 |
|
Administative clerks |
|
|
|
|
|
|
|
|
7 |
88 |
|
Health information technicians |
|
|
|
|
|
|
|
|
7 |
89 |
|
Receptionists |
|
|
|
|
|
|
|
|
7 |
90 |
|
File clerks |
|
|
|
|
|
|
|
|
|
|
|
Laboratory personnel |
|
|
|
|
|
|
|
|
7 |
91 |
|
Lab technicians |
|
|
|
|
|
|
|
|
7 |
92 |
|
Radiology technicians |
|
|
|
|
|
|
|
|
|
|
|
State Department of Health and TB Controllers Office |
|
|
|
|
|
|
|
|
7 |
93 |
|
Director |
|
|
|
|
|
|
|
|
7 |
94 |
|
Assistant director |
|
|
|
|
|
|
|
|
7 |
95 |
|
Chief of staff |
|
|
|
|
|
|
|
|
7 |
96 |
|
Infectious diseases chief |
|
|
|
|
|
|
|
|
7 |
97 |
|
Infectious diseases deputy |
|
|
|
|
|
|
|
|
7 |
97 |
|
TB controller |
|
|
|
|
|
|
|
|
7 |
98 |
|
Chief nurse consultant |
|
|
|
|
|
|
|
|
7 |
99 |
|
Communications officers |
|
|
|
|
|
|
|
|
7 |
100 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
Other personnel |
|
|
|
|
|
|
|
|
7 |
101 |
|
Please indicate |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
Check |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
Travel costs |
Total units used or consumed |
Total amount spent |
Who paid for it |
Notes |
|
|
|
|
|
|
|
Vehicle Use (miles) |
|
|
|
|
|
|
|
|
4 |
102 |
|
Vehicle 1 |
|
|
|
|
|
|
|
|
4 |
103 |
|
Vehicle 2 |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
4 |
104 |
|
Per diem |
|
|
|
|
|
|
|
|
4 |
105 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
Training costs |
Total number of each personnel category receiving training |
Number of personnel receiving training who were involved in the contact investigation or support |
Cost per training course |
Duration of the training validity |
Proportion dedicated to the XDR contact investigation |
Who provided the training? (external, or in-house) |
Who paid for it |
Notes |
|
|
|
Training 1 |
|
|
|
|
|
|
|
|
8 |
106 |
|
Participant personnel category 1 |
|
|
|
|
|
|
|
|
8 |
107 |
|
Participant personnel category 2 |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
Training 2 |
|
|
|
|
|
|
|
|
8 |
108 |
|
Participant personnel category 1 |
|
|
|
|
|
|
|
|
8 |
109 |
|
Participant personnel category 2 |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
Costs of incentives and enablers |
Units consumed |
Cost per item |
Who paid for it |
Notes |
|
|
|
|
|
|
|
Incentives to come to health center |
|
|
|
|
|
|
|
|
4 |
110 |
|
Please list |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
Enablers to come to health center |
|
|
|
|
|
|
|
|
4 |
111 |
|
Please list |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 |
Any other miscellaneous costs |
Units consumed |
Cost per unit |
Percent dedicated to XDR contact investigation |
Who paid for it |
Notes |
|
|
|
5 |
112 |
|
Please indicate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
464 |
Total blanks on this page |
|
CDC estimates the average public reporting burden for this collection of information as 2 hours (1.5 hours for the program manager, and 30 minutes for the accountant |
|
|
|
|
|
|
|
|
|
|
|
including the time for reviewing instructions, searching existing data/information sources, |
|
|
|
|
|
|
|
|
807 |
Total blanks on spreadsheet |
|
gathering and maintaining the data/information needed, and completing and reviewing the collection of information. |
|
|
|
|
|
|
|
|
|
|
|
An agency may not conduct or sponsor, and a person is not required to respond to a collection of information |
|
|
|
|
|
|
|
|
|
|
|
unless it displays a currently valid OMB control number. Send comments regarding this burden estimate |
|
|
|
|
|
|
|
|
|
|
|
or any other aspect of this collection of information, including suggestions for reducing burden to CDC/ATSDR |
|
|
|
|
|
|
|
|
|
|
|
Information Collection Review Office, |
|
|
|
|
|
|
|
|
|
|
|
1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0879). |
|
|
|
|
|
|
|
|
|
|
|
Costs to state health departments |
|
|
|
|
|
|
|
|
|
|
|
Estimated cost of investigating and following contacts of an extensively drug resistant patient in the United States |
|
|
|
|
|
|
|
|
|
|
|
Follow-up period to this point |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
Tests and results for TB infection and disease |
Administered |
# positive |
# negative |
# indeterminate |
Notes |
|
|
|
|
|
|
Tuberculin skin testing |
|
|
|
|
|
|
|
|
2 |
113 |
|
Number of tuberculin skin test (TST) placements with TB education |
|
|
|
|
|
|
|
|
5 |
114 |
|
Number of TST test readings |
|
|
|
|
|
|
|
|
|
|
|
IGRA testing |
|
|
|
|
|
|
|
|
5 |
115 |
|
Number of QuantiFERON Gold In-tube (QFT-GIT) IGRA tests |
|
|
|
|
|
|
|
|
5 |
116 |
|
Number of T-spot IGRA tests |
|
|
|
|
|
|
|
|
|
|
|
Testing for TB disease |
|
|
|
|
|
|
|
|
5 |
117 |
|
Number of physical examinations |
|
|
|
|
|
|
|
|
5 |
118 |
|
Number of chest x-rays (CXR) |
|
|
|
|
|
|
|
|
2 |
119 |
|
Number of sputum inductions |
|
|
|
|
|
|
|
|
5 |
120 |
|
Number of smear microscopy and culture tests |
|
|
|
|
|
|
|
|
5 |
121 |
|
Number of nucleic acid amplification (NAA) tests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
Cost of testing for TB infection and disease |
Cost per service |
Who paid for it |
Notes |
|
|
|
|
|
|
|
|
Tuberculin skin testing |
|
|
|
|
|
|
|
|
3 |
122 |
|
Number of tuberculin skin test (TST) placements with TB education |
|
|
|
|
|
|
|
|
3 |
123 |
|
Number of TST test readings |
|
|
|
|
|
|
|
|
|
|
|
IGRA testing |
|
|
|
|
|
|
|
|
3 |
124 |
|
Number of QuantiFERON Gold In-tube (QFT-GIT) IGRA tests |
|
|
|
|
|
|
|
|
3 |
125 |
|
Number of T-spot IGRA tests |
|
|
|
|
|
|
|
|
|
|
|
Testing for TB disease |
|
|
|
|
|
|
|
|
3 |
126 |
|
Physical examinations |
|
|
|
|
|
|
|
|
3 |
127 |
|
Chest X-rays (CXR) |
|
|
|
|
|
|
|
|
3 |
128 |
|
Sputum inductions |
|
|
|
|
|
|
|
|
3 |
129 |
|
Sputum smear and culture tests |
|
|
|
|
|
|
|
|
3 |
130 |
|
Nucleic acid amplification (NAA) tests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 |
Cost of LTBI treatment |
Cost per dose |
Doses taken |
Who paid for it |
Notes |
|
|
|
|
4 |
131 |
|
6H Isoniazid (INH) |
|
|
|
|
|
|
|
|
4 |
132 |
|
9H Isoniazid (INH) |
|
|
|
|
|
|
|
|
4 |
133 |
|
4R Rifampin (RIF) |
|
|
|
|
|
|
|
|
4 |
134 |
|
3HT Isoniazid (INH) Rifapentine (RPT) |
|
|
|
|
|
|
|
|
4 |
135 |
|
Cycloserine (CYC) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
Personnel costs |
Number of personnel |
Total hours spent on XDR contact investigation |
Gross Annual Salary without benefits
|
Percent fringe benefit |
Who paid for it |
Notes |
|
|
|
|
|
Investigative personnel |
|
|
|
|
|
|
|
|
7 |
136 |
|
Outreach workers |
|
|
|
|
|
|
|
|
7 |
137 |
|
Nurse consultants |
|
|
|
|
|
|
|
|
7 |
138 |
|
Statistician |
|
|
|
|
|
|
|
|
7 |
139 |
|
Epidemiologist |
|
|
|
|
|
|
|
|
7 |
140 |
|
Translators |
|
|
|
|
|
|
|
|
|
|
|
Health care providers |
|
|
|
|
|
|
|
|
7 |
141 |
|
Nursing supervisors |
|
|
|
|
|
|
|
|
7 |
142 |
|
Nurses |
|
|
|
|
|
|
|
|
7 |
143 |
|
Physicians |
|
|
|
|
|
|
|
|
7 |
144 |
|
Counsellors |
|
|
|
|
|
|
|
|
7 |
145 |
|
Social workers |
|
|
|
|
|
|
|
|
7 |
146 |
|
Volunteers |
|
|
|
|
|
|
|
|
|
|
|
Administrative personnel |
|
|
|
|
|
|
|
|
7 |
147 |
|
Program managers |
|
|
|
|
|
|
|
|
7 |
148 |
|
Administative clerk |
|
|
|
|
|
|
|
|
7 |
149 |
|
Health information technicians |
|
|
|
|
|
|
|
|
7 |
150 |
|
Receptionists |
|
|
|
|
|
|
|
|
7 |
151 |
|
File clerks |
|
|
|
|
|
|
|
|
|
|
|
Laboratory personnel |
|
|
|
|
|
|
|
|
7 |
152 |
|
Lab technicians |
|
|
|
|
|
|
|
|
7 |
153 |
|
Radiology technicians |
|
|
|
|
|
|
|
|
|
|
|
State Department of Health and TB Controllers Office |
|
|
|
|
|
|
|
|
7 |
154 |
|
Director |
|
|
|
|
|
|
|
|
7 |
155 |
|
Assistant director |
|
|
|
|
|
|
|
|
7 |
156 |
|
Chief of staff |
|
|
|
|
|
|
|
|
7 |
157 |
|
Infectious diseases chief |
|
|
|
|
|
|
|
|
7 |
158 |
|
Infectious diseases deputy |
|
|
|
|
|
|
|
|
7 |
159 |
|
TB controller |
|
|
|
|
|
|
|
|
7 |
160 |
|
Chief nurse consultant |
|
|
|
|
|
|
|
|
7 |
161 |
|
Communications officers |
|
|
|
|
|
|
|
|
7 |
162 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
Other personnel |
|
|
|
|
|
|
|
|
7 |
163 |
|
Please indicate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Check |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17 |
Travel costs |
Total units used or consumed |
Total amount spent |
Who paid for it |
Notes |
|
|
|
|
|
|
|
Vehicle Use (miles) |
|
|
|
|
|
|
|
|
4 |
164 |
|
Vehicle 1 |
|
|
|
|
|
|
|
|
4 |
165 |
|
Vehicle 2 |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
4 |
166 |
|
Per diem |
|
|
|
|
|
|
|
|
4 |
167 |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
Training costs |
Total number of each personnel category receiving training |
Number of personnel receiving training who were involved in the contact investigation or support |
Cost per training |
Duration of the training validity |
Proportion dedicated to the XDR contact investigation |
Who provided the training |
Who paid for it |
Notes |
|
|
|
Training 1 |
|
|
|
|
|
|
|
|
8 |
168 |
|
Participant personnel category 1 |
|
|
|
|
|
|
|
|
8 |
169 |
|
Participant personnel category 2 |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
Training 2 |
|
|
|
|
|
|
|
|
8 |
170 |
|
Participant personnel category 1 |
|
|
|
|
|
|
|
|
8 |
171 |
|
Participant personnel category 2 |
|
|
|
|
|
|
|
|
|
|
|
etc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
Costs of incentives and enablers |
Units consumed |
Cost per item |
Who paid for it |
Notes |
|
|
|
|
|
|
|
Incentives to come to health center |
|
|
|
|
|
|
|
|
4 |
172 |
|
Please list |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Enablers to come to health center |
|
|
|
|
|
|
|
|
4 |
173 |
|
Please list |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20 |
Any other miscellaneous costs |
Units consumed |
Cost per unit |
Percent dedicated to XDR contact investigation |
Who paid for it |
Notes |
|
|
|
5 |
174 |
|
Please indicate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
343 |
Total blanks on this page |
|
|
|
|
|
|
|
|
|
|